www.fdanews.com/articles/156436-boston-scientific-begins-patient-enrollment-in-u-s-clinical-trial-for-use-of-vercise-dbs-system-for-parkinson-39-s-disease

Boston Scientific Begins Patient Enrollment in U.S. Clinical Trial for Use of Vercise DBS System for Parkinson's Disease

June 18, 2013

Boston Scientific has enrolled its first patients in a U.S. trial of its Vercise deep brain stimulation device.
Boston Scientific